Stay updated with breaking news from David Clair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MINNEAPOLIS, May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor...
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the 2024...
MINNEAPOLIS, May 22, 2024 /PRNewswire/ -- Bio-Techne Corporation and Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines...
Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2024. Third Quarter FY2024...